Cytogenetic clonal evolution in myelodysplastic syndromes is associated with inferior prognosis.

about

Cytogenetic clonal evolution in myelodysplastic syndromes is associated with inferior prognosis.

Item

http://www.wikidata.org/entity/Q38659921

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Cytogenetic clonal evolution i ...... iated with inferior prognosis.

@en

type

Item

label

Cytogenetic clonal evolution i ...... iated with inferior prognosis.

@en

prefLabel

Cytogenetic clonal evolution i ...... iated with inferior prognosis.

@en

P1476

Cytogenetic clonal evolution i ...... iated with inferior prognosis.

@en

P2093

Ann-Christin Nolting

http://www.w3.org/2001/XMLSchema#string

Barbara Hildebrandt

http://www.w3.org/2001/XMLSchema#string

Guido Kobbe

http://www.w3.org/2001/XMLSchema#string

Jennifer Kaivers

http://www.w3.org/2001/XMLSchema#string

Judith Neukirchen

http://www.w3.org/2001/XMLSchema#string

Michael Lauseker

http://www.w3.org/2001/XMLSchema#string

Rainer Haas

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

Circos: an information aesthetic for comparative genomics

Validation of the new comprehensive cytogenetic scoring system (NCCSS) on 630 consecutive de novo MDS patients from a single institution.

Revised international prognostic scoring system for myelodysplastic syndromes.

Clinical significance of in vivo cytarabine-induced gene expression signature in AML.

New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge.

Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet.

Clinical and biological implications of driver mutations in myelodysplastic syndromes.

Landscape of genetic lesions in 944 patients with myelodysplastic syndromes.

Acquisition of cytogenetic abnormalities in patients with IPSS defined lower-risk myelodysplastic syndrome is associated with poor prognosis and transformation to acute myelogenous leukemia.

P31

scholarly article

P356

10.1002/CNCR.30917

http://www.w3.org/2001/XMLSchema#string

P407

English

P50

Ulrich Germing

Norbert Gattermann

P577

2017-07-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28746789

http://www.w3.org/2001/XMLSchema#string